Your primary medical professional will likely check your level again in about 3–6 months. A 2021 study suggests that about 11.5% of transgender men receiving HRT develop polycythemia.
If you’re receiving TRT and struggling with fluctuating hematocrit, fatigue, or iron-related symptoms, our expert providers can help you restore balance and achieve optimal wellness. The Endocrine Society recommends close monitoring of hematocrit at baseline, 3–6 months after any dosing change, and annually thereafter to assess response and guide further management (Bhasin et al., 2018).. The reduction in hematocrit after dose fractionation is generally modest; for example, a randomized trial found that splitting the dose resulted in a decrease of less than 1% in hematocrit over 3 months, while more substantial reductions required further dose lowering or temporary suspension of therapy(Okano et al., 2025). Hematocrit typically begins to decrease within weeks after dose adjustment, but most studies report significant changes in hematocrit over 3–6 months of monitoring following regimen changes(Okano et al., 2025; Bhasin et al., 2018). To reduce hematocrit, therapeutic phlebotomy (blood donation or removal) is often recommended. Understanding this unique balance is essential for safe, effective hormone management, and our team at Nervana Medical provides personalized strategies including careful monitoring, dosing adjustments, and iron repletion to optimize health and performance.
Additionally, factors such as age, overall health status, and presence of other medical conditions (like cardiovascular disease) can influence how often testing should occur. This frequency strikes a balance between vigilant monitoring and practicality, considering the gradual nature of changes in RBC levels. These initial tests provide valuable reference points, enabling healthcare providers to assess how the patient’s body responds to TRT. An elevated hematocrit level, particularly above 52%, is a strong indicator of polycythemia and warrants further investigation. In simple terms, hematocrit determines how thick or thin your blood is. Normal hemoglobin levels are crucial for efficient oxygen transportation. This involves recognizing the biological role of testosterone in RBC production, the variations in risk based on the TRT delivery method, and the influence of lifestyle factors.
One of its less known roles is its influence on the production of red blood cells. Polycythemia, a condition characterized by an increased number of red blood cells (RBCs) in the bloodstream, emerges as a notable concern in the context of Testosterone Replacement Therapy (TRT). This increased viscosity can lead to elevated blood pressure and, in some scenarios, a heightened risk of serious health events such as strokes and heart attacks. Polycythemia, in the context of TRT, refers to an increase in the number of red blood cells (RBCs) in the bloodstream. We hypothesized that short-acting testosterone therapy will be physiologic and have lesser effect on hematocrit compared to long-acting TRT.
Doctors may keep some men on every 6-month testing if they are higher risk. Doctors may also recheck liver enzymes, cholesterol, and PSA, depending on the patient’s age and health. If hematocrit is already high, TRT may need to be delayed or started at a lower dose. In this section, we will go step by step through how often testing is needed, why it matters, and what doctors are looking for.
When it’s caused by an external source like testosterone therapy, it’s classified as secondary polycythemia. Polycythemia refers to an abnormal increase in red blood cell (RBC) mass, which thickens the blood and can potentially raise the risk of cardiovascular issues, including blood clots. If you're undergoing testosterone replacement therapy or considering it, understanding the risks and how to manage them is key to ensuring a safe and successful experience.
Normal blood flows smoothly, carrying oxygen and nutrients to organs. The blood becomes thicker, almost like syrup instead of water. The complete blood count (CBC) test provides the main information, and results are usually confirmed with repeat testing. A hematocrit above 52–54% is the key threshold that signals a problem. Without testing, he would not know that his blood is becoming too thick.

Gender: Female

Social links